IM156 (IM-156; IM 156; HL-156A; HL156A) is a metformin/biguanide analog with potential anticancer and neuroprotective activity.

Dorsomorphin 2HCl (formerly BML-275 dihydrochloride) is a reversible and selective AMPK (AMP-activated protein kinase) inhibitor that inhibits AMPK with a Ki of 109 nM in cell-free assays, exhibiting little inhibition against closely related kinases such as ZAPK, SYK, PKCθ, PKA, and JAK3.

Phenformin HCl (ST-50409947; D-08352; W-104144), the hydrochloride salt of phenformin, was a marketed anti-diabetic drug of the biguanide class, but was withdrawn from most markets in the late 1970s due to a high risk of lactic acidosis.

Bempedoic acid (formerly ESP-55016; ETC-1002; ESP55016; ETC1002; Nexletol; Bempedoate) is an ATP-citrate lyase (ACL) inhibitor as well as an activator of hepatic AMP-activated protein kinase (AMPK).

HTH-01-015 is a novel, potent and selective inhibitor of NUAK1( (NUAK family SnF1-like kinase-1) which can serve as useful chemical probes to delineate the biological roles of the NUAK kinases.